Titievsky, Lina
Schuster, Tilman
Wang, Ronnie
Younus, Muhammad http://orcid.org/0000-0002-1103-296X
Palladino, Andrew
Quazi, Kabir
Wajnrajch, Michael P.
Hernandez, Betina
Becker, Pamela S.
Weinreb, Neal J.
Chambers, Christina
Mansfield, Roy
Taylor, Louise
Tseng, Li-Jung
Kaplan, Paige
Funding for this research was provided by:
Pfizer, Inc. (New York, NY, USA).
Article History
Received: 20 December 2021
Accepted: 14 March 2022
First Online: 1 April 2022
Declarations
:
: The Drug Registry protocol was approved by an institutional review board and/or independent ethics committee at each participating site, in accordance with the local legislation and requirements. Before enrollment, a written, signed, and dated informed consent to participate in the Drug Registry was obtained from all patients or from legal guardians of pediatric patients.
: Not applicable.
: LT is a former employee of Pfizer. TS, RW, MY, AP, KQ, MPW, BH, RM, LT, and L-JT are employees of and own stock in Pfizer. NW, CC, and PK served as consultants on the Scientific Steering Committee for this study and received grant/research support from Pfizer. PSB’s institution received grant/research support from Pfizer for her participation on the Scientific Steering Committee for this study.